Sebastian BioPharma Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed
  • (In Progress)

  • Latest Deal Amount
  • $2.5M

  • Investors
  • 2

Sebastian BioPharma General Information

Description

Developer of immuno-oncology therapeutics designed for the treatment of immunotherapy-resistant cancers. The company develops antibody-oligonucleotide conjugate drug candidates that combine tumor-targeted delivery, dual-payload RNA-based mechanisms, modulation of antigen presentation and oncogenic pathways, and preclinical immunology research, enabling oncology researchers and healthcare providers to address immune resistance in solid tumors and expand potential treatment options for cancer patients.

Contact Information

Website
www.sebastianbio.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • 100 Cumming Center
  • Suite 451-C
  • Beverly, MA 01915
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 100 Cumming Center
  • Suite 451-C
  • Beverly, MA 01915
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sebastian BioPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round $2.5M In Progress Pre-Clinical Trials
4. Grant Completed Pre-Clinical Trials
3. Accelerator/Incubator 25-Mar-2026 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2025 $630K Completed Pre-Clinical Trials
1. Capitalization 01-Jan-2022 $630K $630K Completed Pre-Clinical Trials
To view Sebastian BioPharma’s complete valuation and funding history, request access »

Sebastian BioPharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sebastian BioPharma Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nucleate Accelerator/Incubator
MassBio Accelerator/Incubator
To view Sebastian BioPharma’s complete investors history, request access »

Ready to get started?

Request a free trial

Sebastian BioPharma FAQs

  • When was Sebastian BioPharma founded?

    Sebastian BioPharma was founded in 2022.

  • Where is Sebastian BioPharma headquartered?

    Sebastian BioPharma is headquartered in Beverly, MA.

  • What is the size of Sebastian BioPharma?

    Sebastian BioPharma has 3 total employees.

  • What industry is Sebastian BioPharma in?

    Sebastian BioPharma’s primary industry is Drug Discovery.

  • Is Sebastian BioPharma a private or public company?

    Sebastian BioPharma is a Private company.

  • What is Sebastian BioPharma’s current revenue?

    The current revenue for Sebastian BioPharma is .

  • How much funding has Sebastian BioPharma raised over time?

    Sebastian BioPharma has raised $630K.

  • Who are Sebastian BioPharma’s investors?

    Nucleate and MassBio have invested in Sebastian BioPharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process